Evaluation of the Risk of Getting Peripheral Artery Disease in Rheumatoid Arthritis and the Selection of Appropriate Diagnostic Methods
- PMID: 32953298
- PMCID: PMC7491681
- DOI: 10.7759/cureus.9782
Evaluation of the Risk of Getting Peripheral Artery Disease in Rheumatoid Arthritis and the Selection of Appropriate Diagnostic Methods
Abstract
This study aims to review the evidence regarding the association between peripheral artery disease (PAD) and rheumatoid arthritis (RA), as well as influential underlying factors and diagnostic options. Eligible literature was searched in PubMed published up to June 1, 2020, in English. Case studies, case series, reviews, and meta-analyses were excluded. We also excluded non-human studies and those 20 years and older. A total of 44 studies were finally incorporated in the narrative review. The results indicated that compared to controls, RA patients are more prone to PAD. Traditional risk factors, disease-characteristics, vitamin D deficiency, therapy used, and other relevant conditions have a variable effect on overall PAD progression. Studies comparing diagnostic options revealed that vascular function and morphology are connected but are still distinctive processes. In early-stage disease, there are functional alterations in the endothelium that can be controlled by anti-inflammatory medications. Ankle-Brachial Index (ABI) <0.9 might not be quite susceptible to PAD evaluation. Supplemental diagnostic tools could detect vascular disease in the preclinical stage. Most risk factors are adjustable, and the management will have a good impact on vascular health. PAD is mostly subclinical when the therapeutic options have a better impact. Diagnostic modalities should be chosen depending on the features of RA. In addition, multiple diagnostic options increase the accuracy of PAD diagnosis. Future prospective studies with larger populations at different age groups and different disease activity duration are essential to make firm conclusions and better understand the phenomenon of RA and PAD.
Keywords: arterial stiffness; cardiovascular disease; endothelial dysfunction; peripheral artery disease; rheumatoid arthritis; risk factors; vascular obstruction diagnosis.
Copyright © 2020, Sedrakyan et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Screening for Peripheral Artery Disease Using the Ankle-Brachial Index: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. Report No.: 18-05237-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. Report No.: 18-05237-EF-1. PMID: 30260610 Free Books & Documents. Review.
-
The Ankle Brachial Index for Peripheral Artery Disease Screening and Cardiovascular Disease Prediction in Asymptomatic Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Sep. Report No.: 12-05162-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Sep. Report No.: 12-05162-EF-1. PMID: 24156115 Free Books & Documents. Review.
-
Simultaneous inter-arm and inter-leg systolic blood pressure differences to diagnose peripheral artery disease: a diagnostic accuracy study.Blood Press. 2018 Apr;27(2):112-119. doi: 10.1080/08037051.2017.1400903. Epub 2017 Nov 10. Blood Press. 2018. PMID: 29124943
-
Relationship between lower limb vascular characteristics, peripheral arterial disease and gait in rheumatoid arthritis.Int J Rheum Dis. 2019 Nov;22(11):2017-2024. doi: 10.1111/1756-185X.13717. Epub 2019 Oct 27. Int J Rheum Dis. 2019. PMID: 31657155
-
Screening for Peripheral Artery Disease Using the Ankle-Brachial Index: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2018 Jul 10;320(2):184-196. doi: 10.1001/jama.2018.4250. JAMA. 2018. PMID: 29998343 Review.
Cited by
-
Ischemic Heart Disease and Rheumatoid Arthritis-Two Conditions, the Same Background.Life (Basel). 2021 Oct 3;11(10):1042. doi: 10.3390/life11101042. Life (Basel). 2021. PMID: 34685413 Free PMC article. Review.
-
Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy.Life (Basel). 2023 Jan 23;13(2):319. doi: 10.3390/life13020319. Life (Basel). 2023. PMID: 36836675 Free PMC article. Review.
-
Visualizing novel connections and genetic similarities across diseases using a network-medicine based approach.Sci Rep. 2022 Sep 1;12(1):14914. doi: 10.1038/s41598-022-19244-y. Sci Rep. 2022. PMID: 36050444 Free PMC article.
References
-
- Inflammation and atherosclerosis in rheumatoid arthritis. Stevens RJ, Douglas KM, Saratzis AN, Kitas GD. Expert Rev Mol Med. 2005:1–24. - PubMed
-
- Rheumatoid arthritis and macrovascular disease. Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJ. Rheumatology (Oxford) 2003;42:292–297. - PubMed
-
- Arterial stiffness in chronic inflammatory diseases. Roman MJ, Devereux RB, Schwartz JE, et al. Hypertension. 2005;46:194–199. - PubMed
Publication types
LinkOut - more resources
Full Text Sources